Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (original) (raw)

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The Lancet

Jan Glover Bengtsson hasn't uploaded this paper.

Let Jan know you want this paper to be uploaded.

Ask for this paper to be uploaded.